Zdrowie i gospodarka · 18/11/2002

FDA's Peripheral and Central Nervous System Drugs Advisory Committee to Review Amendment of Notice

The Peripheral and Central Nervous System Drugs Advisory Committee will review an amendment to a notice, following a request from the FDA to update the notice, in accordance with a proposal to modify the schedule of certain drugs, which is part of the agency's recently announced plan to update the schedule of controlled substances.